Angelicola, Stefania
Giunchi, Francesca
Ruzzi, Francesca
Frascino, Mariateresa
Pitzalis, Mary
Scalambra, Laura
Semprini, Maria Sofia
Pittino, Olga Maria
Cappello, Chiara
Siracusa, Irene
Chillico, Ilaria Candida
Di Noia, Martina
Turato, Cristian
De Siervi, Silvia
Lescai, Francesco
Ciavattini, Teresa
Lopatriello, Giulia
Bertoli, Luca
De Jonge, Hugo
Iamele, Luisa
Altimari, Annalisa
Gruppioni, Elisa
Ardizzoni, Andrea
Rossato, Marzia
Gelsomino, Francesco
Lollini, Pier-Luigi
Palladini, Arianna https://orcid.org/0000-0001-6105-4895
Funding for this research was provided by:
Ministero della Salute (GR-2018-12368031)
Article History
Received: 3 August 2024
Accepted: 22 December 2024
First Online: 2 January 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). Human samples were collected after the patient gave her informed consent. The protocol was approved by the Ethics Committee Center Emilia-Romagna Region, Italy (GR-2018-12368031). Human samples and metadata including relevant clinical data were de-identified before being shared between laboratories involved in this study. All animal procedures were performed in accordance with European directive 2010/63/UE and Italian Law (No. DL26/2014). Experimental protocols were reviewed and approved by the institutional animal care and use committee of the University of Bologna and by the Italian Ministry of Health with letter 32/2020-PR.
: Not applicable.
: Prof. Andrea Ardizzoni received research grants from Celgene, Bristol-Myers Squibb, Ipsen, and Roche; and honoraria for advisory roles from Bristol-Myers Squibb, Merck Sharp & Dohme, ROCHE, AstraZeneca, and Eli Lilly outside of the submitted work. Dr. Francesco Gelsomino received honoraria or personal fees for the advisory role or consulting from Eli Lilly, Novartis, AstraZeneca, Pfizer, Regeneron and Bristol-Myers Squibb outside the submitted work.